These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20191352)

  • 1. Simple preparation of coated resin complexes and their incorporation into fast-disintegrating tablets.
    Jeong SH; Park K
    Arch Pharm Res; 2010 Jan; 33(1):115-23. PubMed ID: 20191352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
    Jeong SH; Park K
    Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of co-spray dried cushioning agent containing stearic acid for protecting pellet coatings when compressed.
    Li X; Xu DS; Li M; Liu L; Heng P
    Drug Dev Ind Pharm; 2016; 42(5):788-95. PubMed ID: 26289006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
    Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA
    Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compression of pellets coated with various aqueous polymer dispersions.
    Dashevsky A; Kolter K; Bodmeier R
    Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
    Ge Z; Yang M; Wang Y; Shan L; Gao C
    Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melt granulation and heat treatment for wax matrix-controlled drug release.
    Zhang YE; Schwartz JB
    Drug Dev Ind Pharm; 2003 Feb; 29(2):131-8. PubMed ID: 12648009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel zein-based dry coating tablet design for zero-order release.
    Guo HX; Shi YP
    Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using Methocel K4M or Ethocel 7cP as matrix formers.
    Akkaramongkolporn P; Ngawhirunpat T; Nunthanid J; Opanasopit P
    AAPS PharmSciTech; 2008; 9(3):899-908. PubMed ID: 18668370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tablets with material gradients fabricated by three-dimensional printing.
    Yu DG; Yang XL; Huang WD; Liu J; Wang YG; Xu H
    J Pharm Sci; 2007 Sep; 96(9):2446-56. PubMed ID: 17497729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.
    Nart V; Beringhs AO; França MT; de Espíndola B; Pezzini BR; Stulzer HK
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):250-257. PubMed ID: 27770888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
    Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
    Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins.
    Yewale CP; Rathi MN; Kore GG; Jadhav GV; Wagh MP
    Pharm Dev Technol; 2013; 18(2):367-76. PubMed ID: 22023351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions.
    Junyaprasert VB; Manwiwattanakul G
    Int J Pharm; 2008 Mar; 352(1-2):81-91. PubMed ID: 18061381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.